Ph II Study to Evaluate Olaparib With Abiraterone in Treating Metastatic Castration Resistant Prostate Cancer. Read more about Ph II Study to Evaluate Olaparib With Abiraterone in Treating Metastatic Castration Resistant Prostate Cancer.
A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer Read more about A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer
Dose-Finding, Safety and Efficacy Study of RX-0201 Plus Everolimus in Metastatic Renal Cell Cancer Read more about Dose-Finding, Safety and Efficacy Study of RX-0201 Plus Everolimus in Metastatic Renal Cell Cancer
A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies Read more about A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction Read more about Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery Read more about Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery
Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer Read more about Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer Read more about A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor Read more about Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor
Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate Cancer Read more about Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate Cancer